FDA Approves Second Waterless Solution for Dry Eye Disease

The new water-free cyclosporine-based solution is intended to treat the signs and symptoms of dry eye disease.

Related Keywords

China ,Novaliq Gmb , ,European Union ,Drug Administration ,Novaliq Gmbh ,Dry Eye ,Eratoconjunctivitis Sicca Kcs ,Eratitis Sicca ,Icca Syndrome ,Erophthalmia ,Ry Eye Syndrome Des ,Drug Development ,Neoral ,Eye ,Vision Care And Maintenance ,Ophthalmic ,Phthalmic Route Of Administration ,Phthalmic Delivery ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Clinical Research ,Clinical Trials ,Linical Studi ,